154 related articles for article (PubMed ID: 27260520)
1. TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib.
Ho KC; Fang YD; Chung HW; Liu YC; Chang JW; Hou MM; Yang CT; Cheng NM; Su TP; Yen TC
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2155-2165. PubMed ID: 27260520
[TBL] [Abstract][Full Text] [Related]
2. Total metabolic tumor volume on
Tricarico P; Chardin D; Martin N; Contu S; Hugonnet F; Otto J; Humbert O
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38649279
[TBL] [Abstract][Full Text] [Related]
3. Non-Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of (18)F-FDG Uptake at PET-Association with Treatment Response and Prognosis.
Cook GJ; O'Brien ME; Siddique M; Chicklore S; Loi HY; Sharma B; Punwani R; Bassett P; Goh V; Chua S
Radiology; 2015 Sep; 276(3):883-93. PubMed ID: 25897473
[TBL] [Abstract][Full Text] [Related]
4. The value of
van Rossum PSN; Fried DV; Zhang L; Hofstetter WL; Ho L; Meijer GJ; Carter BW; Court LE; Lin SH
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):71-80. PubMed ID: 27511188
[TBL] [Abstract][Full Text] [Related]
5. Comparison of prognostic value of different metabolic response criteria determined by PET/CT in patients with metastatic breast cancer under CDK 4/6 inhibitor treatment.
Önner H; Eren OÖ; Körez MK; Yilmaz F; Kara Gedik G
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(5):319-324. PubMed ID: 37030597
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of [
Sachpekidis C; Weru V; Kopp-Schneider A; Hassel JC; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2699-2714. PubMed ID: 37099131
[TBL] [Abstract][Full Text] [Related]
7. Efficacy evaluation of neoadjuvant immunotherapy plus chemotherapy for non-small-cell lung cancer: comparison of PET/CT with postoperative pathology.
Cheng Y; Chen ZY; Huang JJ; Shao D
Eur Radiol; 2023 Oct; 33(10):6625-6635. PubMed ID: 37515634
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of treatment response by Hopkins criteria on 18 F FDG PET-CT in patients of non-small cell lung cancer and its comparison with PERCIST response criteria.
Dang S; Shivdasani D; Pereira M; Singh N; Rungta R; Roy D; Kesariya J
Nucl Med Commun; 2023 Nov; 44(11):1038-1045. PubMed ID: 37661788
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Lugano Criteria Versus RECIL and PERCIST as Prognostic Factors in Diffuse Large B-Cell Lymphoma.
Tang P; Cui F; Jiang C; Zhou Y; Su M; Tian R
Clin Nucl Med; 2024 Apr; 49(4):308-311. PubMed ID: 38271234
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Metabolic and Morphological Response Criteria for Early Prediction of Response and Survival in NSCLC Patients Treated With Anti-PD-1/PD-L1.
Castello A; Rossi S; Toschi L; Lopci E
Front Oncol; 2020; 10():1090. PubMed ID: 32850315
[No Abstract] [Full Text] [Related]
11. EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies.
Aide N; Lasnon C; Veit-Haibach P; Sera T; Sattler B; Boellaard R
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(Suppl 1):17-31. PubMed ID: 28623376
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of positron emission tomography for the prognosis of immune checkpoint inhibitors (ICIs) in malignant tumors.
Wu Q; Liu J; Zhang Y; Wu S; Xie X
Cancer Immunol Immunother; 2020 Jun; 69(6):927-936. PubMed ID: 32076793
[TBL] [Abstract][Full Text] [Related]
13. EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program.
Lasnon C; Quak E; Le Roux PY; Robin P; Hofman MS; Bourhis D; Callahan J; Binns DS; Desmonts C; Salaun PY; Hicks RJ; Aide N
EJNMMI Phys; 2017 Dec; 4(1):17. PubMed ID: 28560574
[TBL] [Abstract][Full Text] [Related]
14. Comparison of RECIST and iRECIST criteria in patients with advanced lung cancer treated with nivolumab.
Singla R; Jajodia A; Agrawal RK; Rao A; Pasricha S; Batra U
J Cancer Res Ther; 2023; 19(5):1212-1218. PubMed ID: 37787285
[TBL] [Abstract][Full Text] [Related]
15. Tumor response assessment on imaging following immunotherapy.
Berz AM; Dromain C; Vietti-Violi N; Boughdad S; Duran R
Front Oncol; 2022; 12():982983. PubMed ID: 36387133
[TBL] [Abstract][Full Text] [Related]
16. Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer.
Sørensen JS; Vilstrup MH; Holm J; Vogsen M; Bülow JL; Ljungstrøm L; Braad PE; Gerke O; Hildebrandt MG
Diagnostics (Basel); 2020 Nov; 10(12):. PubMed ID: 33255442
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of post-treatment FDG PET/CT in anal canal cancer: A prospective study.
Bailleux C; Zwarthoed C; Evesque L; Baron D; Scouarnec C; Benezery K; Chardin D; Jaraudias C; Chateau Y; Gal J; François E
Radiother Oncol; 2023 Nov; 188():109905. PubMed ID: 37678620
[TBL] [Abstract][Full Text] [Related]
18. International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).
Younes A; Hilden P; Coiffier B; Hagenbeek A; Salles G; Wilson W; Seymour JF; Kelly K; Gribben J; Pfreunschuh M; Morschhauser F; Schoder H; Zelenetz AD; Rademaker J; Advani R; Valente N; Fortpied C; Witzig TE; Sehn LH; Engert A; Fisher RI; Zinzani PL; Federico M; Hutchings M; Bollard C; Trneny M; Elsayed YA; Tobinai K; Abramson JS; Fowler N; Goy A; Smith M; Ansell S; Kuruvilla J; Dreyling M; Thieblemont C; Little RF; Aurer I; Van Oers MHJ; Takeshita K; Gopal A; Rule S; de Vos S; Kloos I; Kaminski MS; Meignan M; Schwartz LH; Leonard JP; Schuster SJ; Seshan VE
Ann Oncol; 2017 Jul; 28(7):1436-1447. PubMed ID: 28379322
[TBL] [Abstract][Full Text] [Related]
19. Patterns of radiological response to tebentafusp in patients with metastatic uveal melanoma.
Roshardt Prieto NM; Turko P; Zellweger C; Nguyen-Kim TDL; Staeger R; Bellini E; Levesque MP; Dummer R; Ramelyte E
Melanoma Res; 2024 Apr; 34(2):166-174. PubMed ID: 38126339
[TBL] [Abstract][Full Text] [Related]
20. PERCIST in Perspective.
O JH; Wahl RL
Nucl Med Mol Imaging; 2018 Feb; 52(1):1-4. PubMed ID: 29391906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
